Insiders Buying Shares In These 3 High-Growth Drug Stocks, Plus 2 Other Noteworthy Sells
By Ganaxi Small Cap Movers:Insiders made noteworthy buys (see definition below) in three high-growth healthcare stocks this past week (May 21 to 25), and sold two others. Insider buys, especially unusually large ones, in stocks trading near their highs may give investors some confidence that knowledgeable insiders are finding value at such elevated prices after a strong surge.The transactions in this article were selected based on a review of over 1,600 separate SEC Form 4 (insider trading) filings last week, as part of our daily and weekly coverage of insider trades. The filings are noteworthy based on the dollar amount sold, the number of insiders buying or selling, and based on whether the overall buying or selling represents a strong pick-up based on historical buying and selling in the stock:Valeant Pharmaceuticals (VRX): VRX develops primarily branded drugs to treat central nervous system disorders, pain and cardiovascular disease. Last week, three corporate insiders,Complete Story »
- Original article
- Login or register to post comments

